This systematic review aimed to map the main findings of published surveys on medicine storage and key determinants among households. The majority of the articles are from Asia and Africa, three from Europe and one from South America, indicating medical storage and related wastage of resources are problems in Asia and Africa. The paucity of published papers in Europe and Oceania should not be attached to the ignorance of the problem in that region; however, this might be because of their drug take-back policies in the form of social campaigns or routine back to pharmacy strategies [73, 75–77]. The present systematic review not only maps global evidence on the modality and causality of household medicine storage but also remarkably addresses possible solutions for dealing with the problem in different contexts.
Given that our systematic review only examined household surveys that quantitatively represent the problem from the consumer’s perspective, the results should be treated with caution. Therefore, a deeper exploration of medicine storage reasons and consequences through qualitative study designs and from other stakeholder’s perspectives (healthcare providers and decision-makers) could be supplementary for our results.
A total of 12750 households were included from 22 household surveys. In 16 studies (72.7%), more than 70% of households had medicine which half of them reported over 90% storage frequency. This high rate of storage raises the incidence of medicines wastage and its potential associated risks. Although in several countries medicine storage can be explained by disease pattern and health problems, for example, a high proportion (Gastrointestinal tract) GIT medicines in Jordan [61], malaria and anti-infective medicines in Tanzania [64], Iran [56], Ethiopia [60], Uganda [19] and Nigeria[24] and heart and diabetes medicines in Palestine [22], India [65] and Mexico [78], however in most of the countries the storage and consequently wastage are due to inappropriate prescription practice and inadequate patient adherence [3, 14, 19, 21, 22, 60, 66, 79].
Patient attitudes and social values are important contributing factors that stimulate medicine storage and wastage in different forms. According to the studies from Saudi Arabia, Kuwait, UAE, Qatar, Oman and India, patients gratify drug prescription as an outcome of their visit to public health facilities [21, 65]. The role of patient attitudes has been confirmed by Hu J et al., and Norris P et al., implying that immigrants from developing countries like China, India, Korea, Egypt and other Asian and African countries have different perceptions towards accessing and use of medicines which triggers irrational use of medicines [80, 81].
This review found evidence confirming that expired medicines were being used by households in low- and middle-income countries [24, 66]. Dayum et al., has reported that more than 97% of Nigerian households used expired medicine or kept them for future use [24]. The same evidence either has been reported from high-income countries. [28, 82] In Australia, households stated that they used expired medicines either one year or longer, after expiration [82].
Based on the literature, to some extent medicine wastage is inevitable because of several reasons such as patient death, treatment failure, medicine change and side effects [37]. Then, to tackle medicine storage and wastage, smaller packages and shorter duration of prescriptions were endorsed as effective approaches by studies from both developed and developing countries [3, 56, 60, 62, 64, 77, 83, 84].
Paracetamol (Acetaminophen) belonging to group N was the most stored medicine among participated households. Although the finding is not surprising because paracetamol is the first-line treatment for pain and fever management [2, 22, 57, 61], however the availability, affordability, convenience, product marketing and misconception about its safety compared to NSAIDs (Non-steroidal anti-inflammatory drugs) has made the paracetamol family be the first choice of self-medication among people [2, 22, 57, 61, 62]. Despite a limited number of studies reported that keeping a limited stock of these medicines might be cost-saving due to lower physician visit [3, 26, 62, 63], but a much larger number of studies warned about the rising rate of self-medication, medicine wastage and its undesirable consequences [26, 85–87]. The second most widely stored medicines were group J (15%). Antibiotics are the most known medicines in this group. Despite most health systems, antibiotics were licensed as prescription-only drugs, but they are easily purchased without a prescription [3, 19, 21, 26, 56, 62]. The discrepancy between the legislation and daily practice, high expectation about antibiotics effectiveness, low awareness regard to antibiotic resistance and adverse events, high cost of physician consultation have cited as reasons for antibiotics storage [88–92]. The same evidence has been presented by Sawair et al., implying that patients visited the second physician because they did not receive antibiotics from the first physician [93].
According to results reported by included studies, categories N (18%), J (15%), and A (14%), are the most stored medicines at home. This systematic review recognized a consistency between storage and wastage of these categories confirming the idea that medicine storage could potentially yield wastage. Inversely the category C, despite getting forth order among stored medicines, was not found among the first ranks of potential and real wasted drugs. Such discrepancies have been attributed to the prescription and dispensing policies by several studies as well as patient’s better compliance with treatment by others [2, 3, 56, 60, 65].
One of the main objectives of our systematic review was to study predicting factors of home storage of medicines, which can provide valuable evidence for designing and administering efficient health policies for mitigating the problem. Because of existing heterogeneity among the included studies, it was not possible to conduct a quantitative analysis of reported results. Thus the quantitative results of studies have narratively been synthesized. The results of the included studies showed that family size, number of employed members, level of education, health insurance coverage, being a woman, higher age group, economic state, presence of chronic illness, were associated with an increased number of home storage.
The positive association between home storage and wastage of medicine and household’s purchasing power (higher income or lower prices) has also been confirmed by studies from high-income countries indicating that the problem is worldwide and factors beyond real health needs determine medicine demand and utilization [28, 76, 94, 95].
According to the findings of this study [22, 56], insurance was recognized as a positive motive for more storage as well as more wastage, suggesting that, although having medical insurance could financially protect household members against catastrophic health expenditures, but the lack of strict control on prescription, selling and demand of medicine could encounter entire health system to the rising cost of unnecessary storage and wastage of medicines. The presence or absence of medical insurance has been introduced as a stronger factor even than family income as a determinant of medicines stored at home [22, 56].
The impact of education on drug storage is interestingly different from that on wastage. Most of the literature reported a positive association between the level of education of the household’s head and the amount of medicine storage [3, 22, 56, 59–61]. However, the number of medicine wastage was reported higher for illiterate or less educated counterparts [2, 3, 24, 59]. It is obvious that education level prevents drug wastage through better compliance with the treatment or better storage practice [3, 19, 22, 26, 59, 61] but according to the studies, educated people also tend to purchase more medicines from retail pharmacies, store medicines for future use and are more prone to self-medication [3, 19, 22, 26, 59, 61].
there are significant differences between men and women in terms of medicine storage modality, amount and wastage. Notwithstanding the higher rate of in-home storage among women [19, 58], the lower wastage rate was linked to households whose stored medicines were organized by female subjects [15]. Other studies have confirmed high storage rates among women [15, 95, 96] with some reasons such as; gender-related physiopathology, lifestyle, contact to the health system and other biological differences such as pregnancy [96, 97]. However other variations such as; women’s tendency to excessive purchase and self-medication, lacks medical reasoning and can potentially be the focal point for improvement [98]. A study by Becker showed that wasted medicine was more frequently used by men than women [83].
To the best of our findings, there was a considerable variation in medicine storage place among studied countries, since the storage location was reportedly associated with decreased adherence, unfavorable clinical outcomes and potentially hazardous consequences [99–101]. WHO guideline [69] seems to be a good solution for this problem in which the appropriate place is keeping medicine in enclosed, at a cool or dry place, at an inaccessible place for children.
Medicine package either can influence storage and wastage. According to the literature, there was a positive association between oversized drugs and home storage especially for acute conditions such as pain or nausea and vomiting. Ekedahl et al., proposed a feasible way to decrease the volume of unused medicines in which a small “starter pack” is prescribed whenever a new treatment is initiated. If the consumption stopped, only small volumes would be stocked or discarded [23]. A recent study by Bach et al., has reported 27 to 30% wastage in 3.5 mg vials of bortezomib compared to 1.5 mg vials [84].
The majority of the studies (72.7%) highlighted that most countries, did not have any guidelines for disposal of medicines, not only imposes a financial burden on society but also creates environmental hazards through the accumulation of chemical ingredients in landfills and freshwater resources. High-income countries have conducted several schemes for disposal of household’s unused medicines which could be adopted as a practical solution for low and middle-income countries. For example, the National Return and Disposal of Unwanted Medicines (Nat RUM) scheme in Australia which provides a route to return leftover medicines to community pharmacies [73]. Studies in Sweden and Australia suggested a unitary medicine take-over system or educational campaigns at the national level instead of state-run programs [71, 73]. In Nebraska, especial boxes placed in pharmacies that allow consumers to return their medicines to the pharmacy [102]. Arkaravichien et al [103]., and Yang et al [104]., proposed that the national health system can provide financial incentives for pharmacies and households who participate in take-back schemes.
Strengths
This systematic review focused on the most important part of the consumption chain which is before medicine wastage and its related harms to the environment. Furthermore, most of the home storage was reviewed and reported which we believe our study results can provide evidence for decision-making at individual and community levels.
Limitation of the study
Since all of the included studies have focused on quantitative analysis of household’s medicine storage, then the household’s preferences or their experiences as one of key influential factors in triggering inappropriate storage or wastage have not addressed decently. The existing heterogeneity in design and results of included studies hampered pooled estimation and drawing consensus on main related concerns.